Cargando…
Generation of molecular-targeting helix-loop-helix peptides for inhibition of the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the dog
Blocking the interaction between CD28 and B7 by cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a potent immune checkpoint that prevents damage to host tissues from excessive immune responses. However, it also significantly diminishes immune responses against cancers and allows cancer cell g...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Veterinary Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412056/ https://www.ncbi.nlm.nih.gov/pubmed/35753760 http://dx.doi.org/10.1292/jvms.21-0318 |
_version_ | 1784775405871300608 |
---|---|
author | RAMANAYAKE MUDIYANSELAGE, Tharanga MR FUJIWARA, Daisuke MICHIGAMI, Masataka WATANABE, Shunichi YE, Zhengmao UEDA, Atsuko KANEGI, Ryoji HATOYA, Shingo FUJII, Ikuo SUGIURA, Kikuya |
author_facet | RAMANAYAKE MUDIYANSELAGE, Tharanga MR FUJIWARA, Daisuke MICHIGAMI, Masataka WATANABE, Shunichi YE, Zhengmao UEDA, Atsuko KANEGI, Ryoji HATOYA, Shingo FUJII, Ikuo SUGIURA, Kikuya |
author_sort | RAMANAYAKE MUDIYANSELAGE, Tharanga MR |
collection | PubMed |
description | Blocking the interaction between CD28 and B7 by cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a potent immune checkpoint that prevents damage to host tissues from excessive immune responses. However, it also significantly diminishes immune responses against cancers and allows cancer cell growth. This study found that recombinant (r) human (h) CTLA-4 specifically binds to canine dendritic cells (DCs) and suppresses the responses of canine T cells to allogeneic DCs. ERY2-4, a peptide targeting rhCTLA-4 selected from a yeast-displayed library of helix-loop-helix (HLH) peptides and improved to have a binding affinity to rhCTLA-4 as strong as that of rhB7, inhibited the binding of rhCTLA-4 to canine DCs. Furthermore, the targeting peptide significantly enhanced the response of canine T cells to allogeneic DCs. These results suggest that the CTLA-4-targeting peptide enhances canine T cell activity by blocking the interaction between canine CTLA-4 on T cells and canine B7 on DCs. This study demonstrates the generation of a new type of immune checkpoint inhibitor, which may be applicable to cancer therapy in dogs. |
format | Online Article Text |
id | pubmed-9412056 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Japanese Society of Veterinary Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-94120562022-08-30 Generation of molecular-targeting helix-loop-helix peptides for inhibition of the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the dog RAMANAYAKE MUDIYANSELAGE, Tharanga MR FUJIWARA, Daisuke MICHIGAMI, Masataka WATANABE, Shunichi YE, Zhengmao UEDA, Atsuko KANEGI, Ryoji HATOYA, Shingo FUJII, Ikuo SUGIURA, Kikuya J Vet Med Sci Immunology Blocking the interaction between CD28 and B7 by cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) is a potent immune checkpoint that prevents damage to host tissues from excessive immune responses. However, it also significantly diminishes immune responses against cancers and allows cancer cell growth. This study found that recombinant (r) human (h) CTLA-4 specifically binds to canine dendritic cells (DCs) and suppresses the responses of canine T cells to allogeneic DCs. ERY2-4, a peptide targeting rhCTLA-4 selected from a yeast-displayed library of helix-loop-helix (HLH) peptides and improved to have a binding affinity to rhCTLA-4 as strong as that of rhB7, inhibited the binding of rhCTLA-4 to canine DCs. Furthermore, the targeting peptide significantly enhanced the response of canine T cells to allogeneic DCs. These results suggest that the CTLA-4-targeting peptide enhances canine T cell activity by blocking the interaction between canine CTLA-4 on T cells and canine B7 on DCs. This study demonstrates the generation of a new type of immune checkpoint inhibitor, which may be applicable to cancer therapy in dogs. The Japanese Society of Veterinary Science 2022-06-24 2022-08 /pmc/articles/PMC9412056/ /pubmed/35753760 http://dx.doi.org/10.1292/jvms.21-0318 Text en ©2022 The Japanese Society of Veterinary Science https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. (CC-BY-NC-ND 4.0: https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Immunology RAMANAYAKE MUDIYANSELAGE, Tharanga MR FUJIWARA, Daisuke MICHIGAMI, Masataka WATANABE, Shunichi YE, Zhengmao UEDA, Atsuko KANEGI, Ryoji HATOYA, Shingo FUJII, Ikuo SUGIURA, Kikuya Generation of molecular-targeting helix-loop-helix peptides for inhibition of the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the dog |
title | Generation of molecular-targeting helix-loop-helix peptides for inhibition of
the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the
dog |
title_full | Generation of molecular-targeting helix-loop-helix peptides for inhibition of
the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the
dog |
title_fullStr | Generation of molecular-targeting helix-loop-helix peptides for inhibition of
the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the
dog |
title_full_unstemmed | Generation of molecular-targeting helix-loop-helix peptides for inhibition of
the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the
dog |
title_short | Generation of molecular-targeting helix-loop-helix peptides for inhibition of
the interaction between cytotoxic T-lymphocyte-associated protein 4 and B7 in the
dog |
title_sort | generation of molecular-targeting helix-loop-helix peptides for inhibition of
the interaction between cytotoxic t-lymphocyte-associated protein 4 and b7 in the
dog |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412056/ https://www.ncbi.nlm.nih.gov/pubmed/35753760 http://dx.doi.org/10.1292/jvms.21-0318 |
work_keys_str_mv | AT ramanayakemudiyanselagetharangamr generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT fujiwaradaisuke generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT michigamimasataka generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT watanabeshunichi generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT yezhengmao generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT uedaatsuko generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT kanegiryoji generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT hatoyashingo generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT fujiiikuo generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog AT sugiurakikuya generationofmoleculartargetinghelixloophelixpeptidesforinhibitionoftheinteractionbetweencytotoxictlymphocyteassociatedprotein4andb7inthedog |